Related Experiment Video
Updated: Dec 25, 2025

Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy
Published on: December 17, 2019
Ten things the hematologist wants you to know about CAR-T cells
Boris Böll1,2, Marion Subklewe3,4,5, Michael von Bergwelt-Baildon6,3,4,5,7
1Department I of Internal Medicine, Hematology-Oncology, Intensive Care Medicine, Center of Integrated Oncology Cologne-Bonn, University Hospital of Cologne, Cologne, Germany. boris.boell@uk-koeln.de.
No abstract available in PubMed .
More Related Videos
09:12Author Spotlight: Advancements in Hypoxia-Sensitive CAR-T Therapy for Enhanced Cancer Immunotherapy
Published on: June 14, 2024
09:34Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography
Published on: February 17, 2022
Related Concept Videos
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Regulation of Hematopoietic Stem Cells
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
Multipotency of Hematopoietic Stem Cells
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Hematopoiesis